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Qualitative Researcha b s t r a c t
Maternal immunization is key to protecting maternal and newborn health. We interviewed pregnant
women in Brazil to identify barriers to and enablers of maternal immunization in the country. In-
depth interviews and focus groups were conducted in Brazil with 60 pregnant women from São Paulo
and Rio de Janeiro at different stages of their pregnancies. Participants were encouraged to discuss views
on safety, efficacy and importance of maternal vaccines, access to vaccines, interactions with healthcare
professionals, and sources of information on vaccine-related matters. There was generally a positive
regard for maternal immunization among the interviewed women, many of whom associated vaccination
with protection of their unborn child. The interviewees cited several reasons for adherence to immuniza-
tion guidelines, including recommendations from healthcare professionals, targeted communication
campaigns, and active use of a vaccination card or booklet. There were no reported barriers for maternal
vaccines. Some women using private healthcare services reported not having been asked about vaccines
at check-ups, which could adversely affect vaccination rates. A rumour that vaccines caused micro-
cephaly which emerged during the Zika outbreak was the most commonly cited reason for choosing
not to vaccinate among the interviewees. This study identified important vaccine confidence builders.
Many of the interviewees critically reflected upon information received, placing themselves as the deci-
sion makers over their health choices. A prominent barrier to maternal immunization was a rumour link-
ing vaccines to microcephaly. To the best of our knowledge, this has not been previously reported in the
literature and requires further investigation into the extent of this issue and how it can be mitigated.
 2021 The Authors. Published by Elsevier Ltd. This is an openaccess article under the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
The reduction of maternal and newborn mortality is a global
health priority [1]. Maternal immunization programmes have been
highly effective at preventing illness in women and newborns [2].
Preventable diseases including influenza, tetanus and pertussis,
can be controlled with adequate maternal vaccination coverage [3].
Brazil’s national immunization programme (Programa Nacional
de Imunizações) was created in 1973 on the heels of an effective
smallpox eradication campaign [4] and at a time of intense health
sector reform, which came to be known as the Brazilian sanitationmovement (movimento sanitarista brasileiro). This reform, driven by
civil societies, led to the introduction of the national Unified Health
System (Sistema Único de Saúde; SUS), established in the 1988 con-
stitution. Despite the expansion of universal health care in Brazil, a
dual public–private system still exists which has perpetuated
inequities in both access and outcomes. SUS is publicly funded
through government and the latter is accessed primarily by high-
income patients, with care paid for either out of pocket or by pri-
vate health insurers [5].
Under SUS, the national government has worked to improve the
availability and affordability of medicines, including vaccines. The
national immunization programme was expanded gradually and
currently accounts for 95% of all vaccines given to the population,
including privately-insured patients [5]. All vaccines are given to
individuals free at the point of use [6].
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pregnancy in Brazil: hepatitis B, dT (diphtheria and tetanus), Tdap
(diphtheria, tetanus and whooping cough) and influenza (in cam-
paigns) [7]. The yellow fever vaccination is only recommended
for pregnant women living in regions with a high risk of exposure
[8]. Maternal immunization has decreased mortality and morbidity
among women in Brazil [9]. Yet coverage of different vaccines vary
widely: in 2020, uptake of the flu vaccine among pregnant women
was 63%, compared to 43% for Tdap and 22% for dT [10].
In addition to diseases that pregnant women were already vul-
nerable to, Brazil was hit by Zika virus in 2013, which circulated
unnoticed for months [11]. When contracted during pregnancy,
Zika can cause permanent neurological dysfunction in the foetus
[12]. The outbreak became an international emergency in 2015,
mostly affecting pregnant women and leaving behind thousands
of newborns with microcephaly [13] and other impairments asso-
ciated with congenital Zika syndrome [14].
1.1. Vaccine confidence: Barriers and predictors of maternal vaccine
acceptance
Vaccine confidence is context specific, and is a spectrum that
goes from complete acceptance to complete refusal of vaccination
[15]. It is influenced by factors such as complacency (when risk
perception is low), convenience (when access is difficult) and con-
fidence (trust in vaccine, providers and systems offering vaccina-
tion) [16].
There is a growing body of literature about the barriers and pre-
dictors of maternal immunization globally. Barriers to maternal
vaccination include safety concerns [17,18]; issues in access to vac-
cination [19]; and rumours [20]. Predictors of maternal immuniza-
tion include recommendation by a healthcare professional (HCP)
[18] and support of family and partner towards maternal vaccina-
tion [21]. Yet, attitudes around maternal immunization in Brazil
remain understudied.2. Methods
2.1. Study site
The research was conducted in two main urban centres in Bra-
zil: São Paulo and Rio de Janeiro. The two cities were selected for
several reasons. First, they are located in two states with different
demographic characteristics and health system configurations.
Second, both cities have high urban demographic concentration
which can facilitate virus contagion. Third, they have active out-
breaks of measles and are endemic to other infectious diseases
including dengue, chikungunya and Zika. This article adheres to
the Standards for Reporting Qualitative Research (SRQR) reporting
guideline [22] (Appendix 1).
2.2. Recruitment
We collaborated with WIN-Gallup International Association
(WIN/GIA), a well-established global research firm, to recruit preg-
nant women and conduct interviews and focus groups in Brazil. In
total, 60 pregnant women from São Paulo (n = 30) and Rio de
Janeiro (n = 30) participated in this study. One screening question
assessing willingness to take vaccines recommended by HCPs was
used to purposively sample women with both positive and nega-
tive attitudes towards maternal immunization. WIN/GIA collabo-
rated with their subsidiaries in Brazil to obtain access to a panel
of participants from which pregnant women were selected. In
addition, both in Rio and São Paulo a trained recruiter was sent
to hospitals, healthcare centres that provide antenatal care, private4701clinics and maternity hospitals to purposively recruit additional
participants. No chain or snowballing recruitment methodology
was needed.
2.3. Data collection
Original data was collected by WIN/GIA, who conducted in-
depth interviews and focus groups, in Portuguese. Data collectors
were experienced professionals briefed on the overall objectives
of study. Data collection took place between February and April
2019 in the two cities. Two topic guides were developed, one for
in-depth interviews and another for focus groups. They were writ-
ten in a way to encourage participants to discuss their views and
opinions freely. Audio files of focus groups and interviews were
translated and transcribed directly into English. Translation from
Portuguese to English was conducted by a professional translator
at WIN/GIA. To ensure the fidelity of the translation, C.S. (a native
Portuguese speaker) compared the English transcripts to audio
recordings for accuracy.
2.4. In-depth interviews
Twenty in-depth interviews were conducted with pregnant
women, either face-to-face or over the phone. Due to mobility lim-
itations from advanced pregnancy, the option of participating over
the phone was given to participants. In instances when a face-to-
face interview was possible, data collection took place at the
research offices of WIN/GIA subsidiaries in São Paulo and Rio de
Janeiro. These offices are not a medical setting and did not repre-
sent any hospital or health centre. The majority of interviews were
conducted in person. Participants were compensated for travel,
subsistence and participation in the research.
2.5. Focus groups
Four focus groups were conducted (two per location). Each
group was composed of 10 women of different ages and stages of
pregnancy. Groups were split into first time pregnancies and sec-
ond or higher pregnancy. All focus groups required participants
to attend in person and were conducted at the country offices of
WIN/GIA. Participants were compensated for travel, subsistence
and participation in the research.
2.6. Data management and analyses
To ensure confidentiality, all data were anonymized. Confiden-
tiality was maintained by using solely the codes assigned (RJ for
Rio de Janeiro and SP to São Paulo) and we ensured participants
cannot be identified through contextual information. Data were
stored anonymously within a secure server on password protected
computers. Only co-investigators cited in the ethics approval have
access to the files.
Transcripts were analysed using NVivo 11 software (QSR Inter-
national, Melbourne, Australia), to develop a grounded theory of
the views and decision-making towards maternal immunization
in Brazil. The data were organised and coded under themes which
emerged when pregnant women were surveyed about different
aspects of maternal immunization.
2.7. Ethical approval
We received approval to conduct secondary data analysis from
the London School of Hygiene & Tropical Medicine ethics commit-
tee in May 2019 (LSHTM ethics ref: 17100). For primary data col-
lection, standard industry verbal and written consent was
obtained by WIN/Gallup International Association (WIN/GIA).
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they were allowed to refuse to answer any question or end the
interview at any time. All participants provided authorization of
the use of data for research purposes only, regardless of research
institution.3. Findings
The ages of the women participating in this study ranged from
18 to 37 years old, with an average age of 27.3. Fifty percent (50%,
n = 31) of participants were first time mothers. Approximately one
third (32%, n = 19) of recruited women were pre-identified as hav-
ing negative attitudes towards vaccines. The findings of this study
have been categorized into six themes: experience accessing
maternal vaccination in Brazil; maternal immunization as moral
responsibility and strategy of care for children; system confidence
builders; pregnant women as the main decision makers; critical
engagement with maternal vaccine information online; and per-
ceptions of vaccine safety and post-Zika outbreak rumours3.1. Experience accessing maternal vaccination in Brazil
Most participants reported good access to maternal immuniza-
tion and did not report any impediments (e.g. distance to clinic,
financial impediment). Poor access was reported only for the
non-universally recommended yellow fever vaccination.
Participants reported a mixed use of private and public care ser-
vices and vaccines were usually received in public services: ‘‘I’m
doing all pre-natal privately, but I vaccinate in the public system”
(RJ). The ease of access of maternal immunization within the public
system shows in this mother’s preference for vaccinating at a pub-
lic hospital: ‘‘At the moment the (public) health system is provid-
ing vaccines so well that even if it would be easier (to vaccinate at a
private clinic), I wouldn’t do it” (RJ).3.2. Maternal immunization as moral responsibility and strategy of
care for children
Pregnant women discussed taking proactive responsibility for
maternal immunization. A number of participants reported more
awareness of vaccination during pregnancy: ‘‘If I wasn’t pregnant
I wouldn’t take all these vaccines” (SP). The perception of vaccina-
tion as more important during pregnancy was associated with
being a good mother. There was a strong association between
maternal vaccination and a strategy of care to protect their chil-
dren. "We’re carrying a life inside of us, so we must protect it”
(RJ). There is also a view of maternal vaccination as a moral respon-
sibility: ‘‘I took all the vaccines, it is my responsibility (. . .) for the
baby” (SP).
Interestingly, participants mentioned caring for their children
not only to justify accepting vaccination, but also when refusing.
Here, both vaccination and non-vaccination can be seen as strate-
gies of care – refusing vaccination can be seen as protection when
the mother believes the vaccine could harm their child.3.3. System confidence builders
Most participants mentioned three main factors as pivotal to
their decision to vaccinate: the vaccination card, government com-
munication campaigns targeting pregnant women, and recommen-
dation by their HCPs.47023.4. Vaccination card/booklet
The vaccination card or booklet (Cartão de vacinação, in Por-
tuguese) is used by both pregnant women and HCPs as a reference
for information, and to have a record of which vaccines have been
taken. Most participants mentioned HCPs (mostly those from the
public system) asked for their vaccination card: ‘‘(The vaccination
booklet) was one of the first things my doctor checked” (RJ). Preg-
nant women held HCPs accountable when their cards were not
checked: ‘‘The doctor should have asked for my vaccination card
in the first place to check which vaccines I had taken” (SP). Relying
on the vaccination card lessens the importance of previous knowl-
edge about recommended vaccines.
The vaccination card is regarded with the same importance as
other official documents, e.g. a national identity (ID) card. This per-
ceived importance is likely related to the many card checks. These
occur at different stages in their interactions with the public
healthcare system, including delivery: ‘‘When you go into labour,
they check your vaccination card first” (SP). At times, the informa-
tion on the vaccination card trumped HCPs orientation: ‘‘Even if it
is a doctor recommending a vaccine not indicated in the vaccina-
tion booklet, I wouldn’t take it” (RJ).
3.5. Government immunization communication campaigns
Communication campaigns targeting pregnant women were
cited by many as a valuable and reliable source of information
and often cited as a reason to vaccinate. ‘‘If it is in the vaccine
(communication) campaign, I’ll take it” (RJ). ‘‘In Brazil there are
all kinds of diseases, so if you see a campaign you don’t think twice.
You just vaccinate” (RJ).
3.6. HCP recommendation and hierarchies of knowledge
HCPs are seen as a trustworthy source and their recommenda-
tion is a strong factor for acceptance among participants. The main
reason for trusting HCPs was their expertise. To participants, HCPs
have undergone intense formal education and are best equipped to
provide information: ‘‘HCPs are the only ones prepared to answer
questions (about vaccines). They have the knowledge, they studied
for that” (RJ).
3.7. Pregnant women as the main decision-makers
Pregnant women in this study identified themselves as the
main decision-makers in their overall health choices, including
vaccination. One participant emphatically replied, when asked
whose influence was the greatest in her decision: ‘‘I rely more on
me!” (RJ).
While placing themselves as the main decision-makers, most
participants welcome conversations about their health with fam-
ily: ‘‘I take the decisions myself (. . .) but I do ask my mother”
(SP). Another participant stressed her pivotal role in decision-
making in relation to her husband: ‘‘I stick to what’s on my mind.
I talk to him (husband) but if I don’t like his answer, I do what I
want” (RJ).
3.8. ‘‘Frommy phone, I could rule the world”: Critical engagement with
maternal vaccine information online
Pregnant women widely reported searching online for informa-
tion (including vaccination) and felt this was an important part of
their decision-making process, a part that allowed them more con-
trol over their own health. One mother reported on a feeling of
empowerment and self-ownership through digital technologies:
‘‘From my phone, I could rule the world!” (SP).
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what they read online. Information is not passively absorbed but
considered with reflexivity: ‘‘I look online but I am really careful
with the answers” (SP). Most participants discussed concerns
about veracity: ‘‘There is the fake news problem, many things
online are not true (. . .). Unfortunately, the same way the internet
can help with information, it might bring lies and problems" (RJ).3.9. Perceptions of vaccine safety and post-Zika outbreak rumours
Most participants felt safer vaccinating: ‘‘(I vaccinate) to feel
safe (. . .); I’ll be protected and also my child” (RJ). Safety concerns
mostly related to milder reactions (fever, local pain) and most par-
ticipants preferred to risk vaccinating rather than be left
unprotected.
However, among vaccine-refusing women surveyed, safety was
the main reason not to vaccinate: ‘‘I fear my baby will have micro-
cephaly because of the vaccine” (RJ). This reflects the reality of
being pregnant after an outbreak that largely affected expecting
mothers.
Following probing, women discussed the association between
Zika and microcephaly as a cover up: ‘‘I remember pregnant
women vaccinating following a campaign and after that, there
were many cases of microcephaly. (. . .) People said it came from
a mosquito, but this is to cover their mistake” (RJ). Participants
reported suspicions over government initiatives: ‘‘We are losing
trust in our government. We saw many cases of babies born with
deformities, and people say it was because of the vaccine. We don’t
know if it’s true, but we are scared. I think this government isn’t
good, and our level of suspicion is increasing because vaccines
were always safe” (SP).4. Discussion
Many important elements surrounding confidence in maternal
immunization in Brazil were identified in this study. Participants
generally reported good access to vaccinations and ease of access
through the public system contributed to participants’ overall pos-
itive. Many participants reported barriers to yellow fever vaccina-
tion in public health centres, likely due to lack of universal
recommendation for pregnant women.
Participants were not complacent, holding a strong view that
maternal immunization is an important strategy of care. Pregnant
women reported it is their responsibility, as good mothers, to pro-
tect their babies. The fact that diseases which they vaccinate
against are no longer common does not make women complacent
– differently from other settings where absence of disease is cited
as reason not to vaccinate during pregnancy [23].
There are important system confidence builders (e.g. HCP rec-
ommendation, government campaigns). This study particularly
identified the positive regard participants have for their vaccina-
tion card and the many card checkpoints within the health system
and beyond. Among participants, HCP recommendation is a strong
factor for maternal vaccine acceptance. This is in agreement with
overall literature on maternal immunization that places HCP rec-
ommendation as one of the leading factors for uptake [18].
Self-identifying as a critical thinker has been as a reason for
mothers not to trust HCPs or disregard scientific information
[24]. In this study, however, their critical assessment of maternal
immunization starts with trust in HCPs while using multiple
sources to inform their decision. As information-seeking behaviour
can be heightened among pregnant women [25], in addition to
consulting their HCPs, many participants gathered information
from family and internet searches, and ultimately trusted them-
selves to make an informed decision. In particular, the use of4703smartphones and the internet to obtain information was perceived
as empowering and important step in their decision-making.
Women who used private healthcare services were not asked
about vaccines as consistently. This study suggests HCPs from
the public system are stricter about follow up with vaccinations.
Considering the mixed use of private and public systems in Brazil,
this calls for attention as it could affect maternal immunization
coverage.
The suspicion that vaccines can cause microcephaly is acknowl-
edged as a possible barrier for confidence in maternal immuniza-
tion. To the best of our knowledge, this is not yet documented in
the literature. A common rumour during the Zika outbreak incor-
rectly associated microcephaly to vaccines [26]. The full impact
of the Zika outbreak on trust in the healthcare system, HCPs, and
vaccination remains unclear and more investigation is needed.
While rumours can generally be seen as a result of misinformation
[27], authors have emphasized the social significance of rumours,
which can stem from deep mistrust of actors, government and
institutions [28]. Rumours, then, are not simple misunderstandings
but can convey more generalized concerns about medical interven-
tions. Consequently, rumours can be more effectively addressed
through active dialogue rather than correcting misinformation [29]
More research is needed to understand reasons for low uptake
of some maternal vaccines in Brazil. There are many potential con-
tributors, including vaccine hesitancy, supply issues, budgetary
pressures and broader access issues [30]. Given the reported con-
cerns and rumours over safety of vaccines found in this study,
future research could examine how this uneasiness might be
impacting decision-making. It is also possible that there are pock-
ets of vaccine hesitancy in other parts of Brazil (outside Rio de
Janeiro and São Paulo), which could help explain low uptake of cer-
tain immunizations. It is important to investigate regional differ-
ences in attitudes towards maternal vaccines, as well as attitudes
towards specific vaccines (i.e. influenza vaccine, DTap).
4.1. Limitations
This study has limitations. As a qualitative study, findings cap-
ture experiences not easily assessed in quantitative investigations.
Yet results may not be transferable to other regions. Second, both
cities are two of the richest in the country. Therefore, access to vac-
cines is not necessarily the same as in other regions that do not
have the same financial capacity. Lastly, some participants were
recruited in health facilities and hence prone to use basic health
services such as immunization, which might have produced such
findings.5. Conclusion
Maternal health has long been a public health priority in Brazil,
with optimal maternal immunization a core component. This study
attempted to assess views and attitudes of pregnant women and
understand relevant factors in their decision-making process. The
findings encompass system components to ways in which preg-
nant women reflect upon information received from different
sources, including HCPs and internet searches. A possible barrier
to maternal immunization identified was a rumour that blamed
vaccines for microcephaly cases, which requires further
investigation.
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